<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03642457</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 17-1294</org_study_id>
    <nct_id>NCT03642457</nct_id>
  </id_info>
  <brief_title>Efficacy Between Serratus Plane Block And Local Infiltration In Vats</brief_title>
  <official_title>Comparison Between Serratus Plane Block And Local Surgical Infiltration In Robotic Video Assisted Thoracoscopic Surgery- A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Robotic video-assisted thoracoscopic surgery (VATS) is increasingly being used as it is a
      less invasive surgery compared to traditional methods, but the acute pain at an early stage
      after VATS has a major impact on perioperative outcomes. Effective post operative analgesia
      is believed to reduce morbidity, quicken recovery, improve patient outcome and reduce
      hospital costs. The site and extent of the incision influences the degree of pain due to
      disruption of intercostal nerves as well as inflammation of chest wall and pleura. Neuraxial
      and systemic opioids have been a gold standard as a part of multimodal analgesia for thoracic
      surgeries. Numerous modalities have been studied: thoracic paravertebral nerve blocks,
      thoracic epidural analgesia, intercostal nerve blocks, patient controlled analgesia (PCA),
      cryo-analgesia, transcutaneous electrical nerve stimulation (TENS), inter-pleural blocks,
      stellate ganglion blocks, long thoracic nerve blocks, and infiltration under direct vision by
      the surgeon.

      Serratus plane block is an emerging regional technique that has proven to be effective in
      comparison to paravertebral blocks in patients undergoing breast surgery and mastectomy with
      reduced perioperative opioid consumption and improved pain scores.

      The lateral pectoral nerve, medial pectoral nerve, intercostal nerves and long thoracic nerve
      are all targets for the serratus plane block. It can be safely performed under ultrasound
      guidance.

      The purpose of the study is to evaluate the difference in quality of analgesia between
      efficacy of serratus plane block and local surgical infiltration by surgeon as measured by
      patient opioid consumption and pain scores.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be assigned randomly using a computer-generated table of numbers to either
      serratus group or infiltration group. Block team will perform all blocks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>The patient, surgeon, and anesthesiologist in the case will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of opioid consumption</measure>
    <time_frame>up to 24 hours post procedure</time_frame>
    <description>The amount of opioid consumption (in mg IV morphine equivalents) postoperatively up to 24 hours after the</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first dose of narcotic administration</measure>
    <time_frame>up to 24 hours post procedure</time_frame>
    <description>Time to first dose of narcotic administration post procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACU or ICU length of stay</measure>
    <time_frame>up to 24 hours post procedure</time_frame>
    <description>The length of stay post procedure in the PACU or ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score (VAS)</measure>
    <time_frame>up to 24 hours post procedure</time_frame>
    <description>Visual Analogue Score (VAS) pain score from 0 (no pain) to 10 (most pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score</measure>
    <time_frame>up to 24 hours post procedure</time_frame>
    <description>Patient satisfaction score from 0 (not satisfied) to 10 (extremely satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Serratus Plane Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the group will receive a total 20cc of solution consisting of 0.5% bupivacaine with 133mg of liposomal bupivacaine injected in the serratus plane with the help of an ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients randomized to the group will receive a total 20cc of 133mg liposomal bupivacaine injected prior to skin closure at the incision site as per surgeon's practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>20 cc 0.5%</description>
    <arm_group_label>Serratus Plane Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine liposome</intervention_name>
    <description>133mg liposomal bupivacaine</description>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_label>Serratus Plane Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA (American Society of Anesthesiology) class I-IV

          -  age 81-75

        Exclusion Criteria:

          -  ASA class V

          -  morbid obesity

          -  patient refusal

          -  patients with chronic pain or on pain medications

          -  allergy to LA

          -  patients receiving any additional regional techniques

          -  coagulopathy

          -  patients receiving systemic anticoagulation

          -  local infection

          -  procedures anticipated to last more than 5 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Lai, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>cahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Poonam Pai B.H, MD</last_name>
    <phone>212-523-4000</phone>
    <email>PHEBBALASANKATTE@CHPNET.ORG</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mount Sinai St. Luke's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Poonam Pai B.H, MD</last_name>
      <phone>212-523-4000</phone>
      <email>poonam.paibantwalhebbalasankatte@mountsinai.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai West Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Poonam Pai B.H, MD</last_name>
      <phone>212-523-4000</phone>
      <email>poonam.paibantwalhebbalasankatte@mountsinai.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kulhari S, Bharti N, Bala I, Arora S, Singh G. Efficacy of pectoral nerve block versus thoracic paravertebral block for postoperative analgesia after radical mastectomy: a randomized controlled trial. Br J Anaesth. 2016 Sep;117(3):382-6. doi: 10.1093/bja/aew223.</citation>
    <PMID>27543533</PMID>
  </reference>
  <reference>
    <citation>Blanco R. The 'pecs block': a novel technique for providing analgesia after breast surgery. Anaesthesia. 2011 Sep;66(9):847-8. doi: 10.1111/j.1365-2044.2011.06838.x.</citation>
    <PMID>21831090</PMID>
  </reference>
  <reference>
    <citation>Thoracic paravertebral block versus pectoral nerve block for analgesia after breast surgery. Egypt J Anaesth. 2013; 30: 129-135. Wahba, SS and Kamal, SM.</citation>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>August 20, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>April 19, 2019</last_update_submitted>
  <last_update_submitted_qc>April 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Yan Lai</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Video assisted thoracoscopic surgery</keyword>
  <keyword>Serratus plane block</keyword>
  <keyword>local infiltration</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

